We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The Trump administration last week unveiled a pilot Medicaid program that would allow participating states to negotiate drug prices by choosing the drugs covered for certain adults under age 65 — an approach that PhRMA strongly opposes. Read More
Drugmakers are ramping up efforts to develop countermeasures for the coronavirus outbreak, which the World Health Organization yesterday declared a global health emergency. Read More
Innovative cancer drugs are taking longer to get from clinical trials to EMA approval and availability for UK patients than more conventional treatments, the London-based Institute of Cancer Research (ICR) reported. Read More
A House subcommittee took up four bipartisan drug bills yesterday, including one — introduced in October — that would close a loophole in the FDA’s orphan drug program. Read More